Advantages
Current Stage and Key Data
Partnering Model
Background and Technology
Principal Investigator
Patents and Publications
Patents and Publications
Patents
- (1) PCT/JP2016/052485 [anti-CKAP4 antibodies]
- JP (Issued: 6,316,498)
- US (Issued: 10,618,954)
- EP (Granted: 2025-Nov-12) pub. # EP3287143(A4)
- CN (Issued: 10,724,9636)
- CA (Issued: 2,977,917)
- (2) PCT/JP2018/035719 [anti-CKAP4 mouse mAbs]
- US (Issued: 11,807,679)
- EP (pend.) pub. # EP3690051(A4)
- CA (Issued: 3,076,997)
- (3) PCT/JP2024/020940 [anti-CKAP4 humanized mAbs]
- Pending.
Publications
- Kimura H, et al., J. Clin. Invest. (2016) 126, 2689–2705.[DOI] https://doi.org/10.1172/JCI84658
- Shinno N, et al., Oncogene (2018) 37, 3471–3484.[DOI] https://doi.org/10.1038/s41388-018-0179-2
- Kajiwara C, et al., Cancer Res. (2018) 78, 6107–6120.[DOI] https://doi.org/10.1158/0008-5472.can-18-1749
- Kimura H, et al., Clin Cancer Res (2019) 25, 1936–1947.[DOI] https://doi.org/10.1158/1078-0432.CCR-18-2124